Grow with us in 2015!
InSphero January Newsletter
Dear <<First Name>>,

If your 2015 resolution was to upgrade your in vitro assays to incorporate 3D cell models, look no further than the EU MIP-DILI project as further justification for sticking to your resolution.  3D microtissues continue to prove their value as more predictive organotypic model systems, and InSphero is here to serve as your 3D "personal trainer" along the way.  We invite you to grow with us in 2015! 

MIP-DILI Using 3D Liver Spheroids
Product Focus: Liver Microtissues
Nanotox PFT Article One of 2014's Most Shared

Company & Distributor News
InSphero IP Portfolio Continues Growth

Automation & Imaging
Spheroid-based Body on Chip Published in Lab Automation
Meet InSphero at SLAS 2015


MIP-DILI Using 3D Liver Spheroids

Remarking that 3D Liver Spheroids provide "superior biological relevance...scalability and compatibility," leaders of the MIP-DILI consortium are moving forward with further testing of liver spheroids as a means to predict clinical safety of new drugs.  Read the press release.

InSphero IP Portfolio Continues Growth

Users of the GravityPLUS™ Cell Culture and Assay Platform know first-hand the benefits our technology brings to their 3D workflow.  International IP protection for our technology grew in 2014, and our scientists continue their mission to bring novel 3D technology to your bench top.  Read more.


3D InSight™ Liver Microtissues

InSphero's assay-ready 3D InSight™ Human, Rat and HepG2 Liver Microtissues are setting the standard for long-lived, organotypic in vitro models for safety testing, DMPK studies, mechanistic toxicity, and disease modeling.  Learn more in our on-demand webinars.


Lab Automation: Spheroid-based Body on Chip

The December 18 issue of Laboratory Automation featured a glimpse into the future of Body-on-a-Chip technology.  Co-authored by InSphero's Dr. Jens Kelm and Dr. David Fluri, the system allows connection of up to 66 microtissues of different cell types.  View the PubMed abstract.

We Published, You Shared!

Did you miss our nanotox article in last October's Particle and Fibre Toxicology?  Those who read it tended to pass it along, as it ranked as one of the "Top 4 Social" articles the journal published last year.  Learn more.



Meet InSphero at SLAS 2015

Heading to SLAS in Washington, DC?  Visit our SLAS conference page to learn more about our meeting activities.  Highlights include a podium presentation by CSO and co-founder Dr. Jens M. Kelm featuring recent body on a chip work, as well as our 3D cell culture short course, 3D cell-based assay tutorial, and more. Join us!


Now hiring. 
View current openings

Copyright © 2015 InSphero, All rights reserved.